Elemental Capital Partners LLC lifted its stake in Lam Research Corporation (NASDAQ:LRCX – Free Report) by 5.8% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 51,302 shares of the semiconductor company’s stock after acquiring an additional 2,802 shares during the quarter. Lam Research makes up 4.7% of Elemental Capital Partners LLC’s portfolio, making the stock its 5th biggest holding. Elemental Capital Partners LLC’s holdings in Lam Research were worth $8,782,000 as of its most recent filing with the Securities and Exchange Commission.
Other institutional investors have also recently bought and sold shares of the company. PMV Capital Advisers LLC acquired a new position in Lam Research in the 4th quarter worth about $25,000. Stance Capital LLC purchased a new stake in shares of Lam Research during the 3rd quarter worth about $26,000. Howard Hughes Medical Institute acquired a new stake in shares of Lam Research during the 2nd quarter valued at about $27,000. Triumph Capital Management bought a new stake in shares of Lam Research in the 3rd quarter valued at approximately $27,000. Finally, Strategic Wealth Investment Group LLC bought a new stake in shares of Lam Research in the 2nd quarter valued at approximately $29,000. Institutional investors and hedge funds own 84.61% of the company’s stock.
Insider Buying and Selling at Lam Research
In other news, CFO Douglas R. Bettinger sold 50,057 shares of the firm’s stock in a transaction dated Wednesday, March 4th. The stock was sold at an average price of $224.03, for a total value of $11,214,269.71. Following the sale, the chief financial officer directly owned 1,081,705 shares of the company’s stock, valued at approximately $242,334,371.15. This trade represents a 4.42% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, insider Ava Harter sold 1,500 shares of Lam Research stock in a transaction dated Wednesday, March 4th. The stock was sold at an average price of $222.66, for a total value of $333,990.00. Following the completion of the transaction, the insider owned 53,205 shares in the company, valued at $11,846,625.30. The trade was a 2.74% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 130,886 shares of company stock worth $29,658,802 over the last ninety days. Company insiders own 0.31% of the company’s stock.
Lam Research Trading Down 1.6%
Lam Research (NASDAQ:LRCX – Get Free Report) last issued its quarterly earnings data on Wednesday, January 28th. The semiconductor company reported $1.27 earnings per share for the quarter, topping analysts’ consensus estimates of $1.17 by $0.10. The business had revenue of $5.34 billion during the quarter, compared to analysts’ expectations of $5.23 billion. Lam Research had a net margin of 30.22% and a return on equity of 62.81%. Lam Research’s revenue for the quarter was up 22.1% on a year-over-year basis. During the same period in the previous year, the company earned $0.91 earnings per share. Lam Research has set its Q3 2026 guidance at 1.250-1.450 EPS. Equities analysts predict that Lam Research Corporation will post 3.71 EPS for the current year.
Lam Research Announces Dividend
The company also recently declared a quarterly dividend, which will be paid on Wednesday, April 8th. Shareholders of record on Wednesday, March 4th will be issued a dividend of $0.26 per share. This represents a $1.04 dividend on an annualized basis and a yield of 0.5%. The ex-dividend date is Wednesday, March 4th. Lam Research’s dividend payout ratio is 21.31%.
Wall Street Analysts Forecast Growth
Several brokerages recently weighed in on LRCX. Susquehanna set a $325.00 price objective on shares of Lam Research and gave the company a “positive” rating in a research report on Thursday, January 29th. Bank of America boosted their target price on shares of Lam Research from $195.00 to $245.00 and gave the stock a “buy” rating in a research report on Tuesday, January 13th. KeyCorp restated a “sector weight” rating on shares of Lam Research in a research note on Thursday, January 29th. Summit Insights upgraded shares of Lam Research from a “hold” rating to a “buy” rating in a report on Thursday, January 29th. Finally, New Street Research lifted their price objective on shares of Lam Research from $140.00 to $235.00 and gave the company a “neutral” rating in a research note on Tuesday. One investment analyst has rated the stock with a Strong Buy rating, twenty-seven have assigned a Buy rating and seven have given a Hold rating to the stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $245.35.
Check Out Our Latest Research Report on Lam Research
Key Headlines Impacting Lam Research
Here are the key news stories impacting Lam Research this week:
- Positive Sentiment: AI-driven demand positions Lam as a “pick-and-shovel” beneficiary — analysts note semiconductor equipment names like LRCX are surging as AI chip capex lifts long-term revenue potential. 2 AI Pick-and-Shovel Stocks Poised to Be the Next NVIDIA
- Positive Sentiment: Bullish fundamental coverage — Seeking Alpha highlights Lam’s strong margins, improved operating efficiency and positioning as a critical etch-equipment supplier to foundries, supporting longer-term growth expectations. Lam Research: Poised For Growth, Looking Past Short-Term Turbulence
- Positive Sentiment: Price-target lift: New Street Research raised its target to $235 (from $140) — signaling higher valuation potential even while keeping a neutral rating, which can underpin upside expectations. New Street adjusts price target on Lam Research to $235
- Neutral Sentiment: Corporate calendar: Lam set its March-quarter earnings conference call for April 22 — a near-term event that could drive volatility depending on guidance and commentary. Lam Research Corporation Announces March Quarter Financial Conference Call
- Neutral Sentiment: Notable investor moves: Coverage notes Ray Dalio’s Bridgewater trimmed its Lam stake — signals attention from large holders but not necessarily a directional verdict. Lam Research Corporation (LRCX): Billionaire Ray Dalio Trims Stake in Chip Stock
- Negative Sentiment: Analyst downgrade: Erste Group cut LRCX from “buy” to “hold,” adding near-term selling pressure as momentum investors react. Finviz: Analyst downgrade
- Negative Sentiment: Regulatory risk: U.S. lawmakers unveiled draft legislation to tighten exports of chipmaking tools to China — broader restrictions would reduce addressable markets for equipment suppliers and increase geopolitical uncertainty. US Lawmakers Propose Crackdown on Chip Tool Sales to China
About Lam Research
Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.
Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.
See Also
Want to see what other hedge funds are holding LRCX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Lam Research Corporation (NASDAQ:LRCX – Free Report).
Receive News & Ratings for Lam Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lam Research and related companies with MarketBeat.com's FREE daily email newsletter.
